CG
GH icon

Cutler Group’s Guardant Health GH Stock Holding History

Cutler Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,300
Closed -$1K – 3796
2023
Q1 		$1K Sell
2,300
-2,700
-54% -$77.1K ﹤0.01% 3426
2022
Q4 		$20K Sell
5,000
-6,700
-57% -$307K ﹤0.01% 2218
2022
Q3 		$159K Sell
11,700
-100
-0.8% -$5.13K 0.01% 1095
2022
Q2 		$330K Sell
11,800
-6,700
-36% -$332K 0.02% 714
2022
Q1 		$126K Buy
18,500
+9,800
+113% +$671K 0.01% 1528
2021
Q4 		$19K Buy
+8,700
New +$900K ﹤0.01% 3164
2020
Q3 		– Sell
-400
Closed -$1K – 4869
2020
Q2 		$1K Sell
400
-100
-20% -$8.06K ﹤0.01% 4038
2020
Q1 		$5K Buy
+500
New +$38.4K ﹤0.01% 3075
2019
Q4 		– Sell
-2,700
Closed -$36K – 4187
2019
Q3 		$36K Buy
2,700
+1,900
+238% +$167K ﹤0.01% 1770
2019
Q2 		$4K Buy
+800
New +$61.1K ﹤0.01% 3219

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cutler Group's GH Position: Q1 2023 in Review

Cutler Group sold out of Guardant Health (GH) in Q1 2023, closing a stake of 2,917 shares — an estimated $83.3K sold.

Cutler Group first reported a position in GH in Q3 2019 and held it in 8 quarters. The position peaked at $777K in Q3 2022. 278 funds tracked by Wall St. Rank hold GH as of Q1 2023.

  • Cutler Group reported no remaining Guardant Health position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 2,917 Guardant Health shares in Q1 2023, an estimated $83.3K.
  • Cutler Group first reported a position in Guardant Health in Q3 2019 and held it in 8 quarters.
  • Cutler Group's Guardant Health position peaked at $777K in Q3 2022.
  • 278 funds tracked by Wall St. Rank held Guardant Health as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.